Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Clinical Trial of ABI-H0731 (731) in China

Next Previous
Trial Profile

A Clinical Trial of ABI-H0731 (731) in China

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vebicorvir (Primary)
  • Indications Hepatitis B
  • Focus Adverse reactions
  • Sponsors Assembly Biosciences

Most Recent Events

  • 01 Jul 2019 New trial record
  • 21 Jun 2019 According to an Assembly Biosciences media release, the company is collaborating with leading regional experts, including Professor Jinlin Hou, the Director and Professor of the Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, in Guangzhou, China.
  • 21 Jun 2019 According to an Assembly Biosciences media release, the company has received Clinical Trial Application (CTA) approval from Chinas Center for Drug Evaluation (CDE), part of the National Medical Products Administration (NMPA) in China with the plans to initiate the clinical trial of ABI-H0731 (731) at designated leading HBV trial sites in China this year.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top